TTK Healthcare Limited completed the sale of its "EVA" and "Good Home" brands to Wipro Enterprises Private Limited on September 4, 2026. The company received ₹256 crore plus applicable GST as cash consideration, finalizing the transaction announced two months earlier.

The deal closes pursuant to definitive agreements entered into on July 23, 2026. TTK Healthcare disclosed the completion under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, confirming receipt of the full consideration amount.

Transaction Details

The sale involves the transfer of the "EVA" and "Good Home" brand assets. Wipro Enterprises Private Limited acquired these brands for a total cash consideration of ₹256 crore, excluding Goods and Services Tax (GST).

Gowry A Jaishankar, DGM - Legal & Company Secretary at TTK Healthcare, signed the disclosure filed with the Bombay Stock Exchange and the National Stock Exchange of India.

TTK Healthcare has accepted the resignation of M/s Aiyar & Co. as its tax auditor, effective August 26, 2026. The firm cited regulatory ineligibility under Institute of Chartered Accountants of India (ICAI) guidelines as the reason for stepping down from the FY25-26 assignment.

The resignation stems from a review of the firm’s Peer Review Certificate issued by the ICAI Peer Review Board. M/s Aiyar & Co. stated that current guidelines restrict their scope, rendering them ineligible to sign audit reports for listed companies. Continuing with the tax audit would violate professional and regulatory standards set by the ICAI.

Regulatory Disclosure

TTK Healthcare disclosed the development under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company also referenced SEBI Master Circular No. SEBI/HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, read with Schedule III of the Listing Regulations.

Next Steps

The Audit Committee and the Board of Directors will initiate action to appoint a new tax auditor for the Financial Year 2025-26. The company noted that the previous acceptance of the assignment was made in good faith before the regulatory scope was clarified.

Gowry A Jaishankar, DGM - Legal & Company Secretary, signed the disclosure letter sent to the BSE and NSE on August 27, 2026.